Darbari Deepika S, Hampson Johnson P, Ichesco Eric, Kadom Nadja, Vezina Gilbert, Evangelou Iordanis, Clauw Daniel J, Taylor Vi James G, Harris Richard E
Division of Hematology, Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC; Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC; Genomic Medicine Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan.
J Pain. 2015 Nov;16(11):1077-86. doi: 10.1016/j.jpain.2015.07.005. Epub 2015 Aug 18.
Sickle cell disease (SCD) is a hemoglobinopathy that affects more than 100,000 individuals in the United States. The disease is characterized by the presence of sickle hemoglobin and recurrent episodes of pain. Some individuals with SCD experience frequent hospitalizations and a high burden of pain. The role of central mechanisms in SCD pain has not been explored. Twenty-five adolescents and young adults with SCD underwent functional magnetic resonance imaging. Participants were stratified into groups with high pain or low pain based on the number of hospitalizations for pain in the preceding 12 months. Resting state functional connectivity was analyzed using seed-based and dual regression independent component analysis. Intrinsic brain connectivity was compared between the high pain and low pain groups, and association with fetal hemoglobin, a known modifier of SCD, was explored. Patients in the high pain group displayed an excess of pronociceptive connectivity such as between anterior cingulate and default mode network structures, such as the precuneus, whereas patients in the low pain group showed more connectivity to antinociceptive structures such as the perigenual and subgenual cingulate. Although a similar proportion of patients in both groups reported that they were on hydroxyurea, the fetal hemoglobin levels were significantly higher in the low pain group and were associated with greater connectivity to antinociceptive structures. These findings support the role of central mechanisms in SCD pain. Intrinsic brain connectivity should be explored as a complementary and objective outcome measure in SCD pain research.
Altered connectivity patterns associated with high pain experience in patients with sickle cell disease suggest a possible role of central mechanisms in sickle cell pain. Resting state brain connectivity studies should be explored as an effective methodology to investigate pain in SCD.
镰状细胞病(SCD)是一种血红蛋白病,在美国影响着超过10万名个体。该疾病的特征是存在镰状血红蛋白以及反复出现的疼痛发作。一些SCD患者经常住院且疼痛负担较重。中枢机制在SCD疼痛中的作用尚未得到探索。25名患有SCD的青少年和青年接受了功能磁共振成像检查。根据前12个月因疼痛住院的次数,将参与者分为高疼痛组或低疼痛组。使用基于种子点和双回归独立成分分析来分析静息态功能连接。比较高疼痛组和低疼痛组之间的内在脑连接性,并探索其与胎儿血红蛋白(一种已知的SCD调节剂)的关联。高疼痛组患者表现出过多的伤害感受性连接,例如前扣带回与默认模式网络结构(如楔前叶)之间的连接,而低疼痛组患者则表现出与抗伤害感受性结构(如膝周和膝下扣带回)更多的连接。尽管两组中报告使用羟基脲的患者比例相似,但低疼痛组的胎儿血红蛋白水平显著更高,并且与抗伤害感受性结构的更强连接相关。这些发现支持了中枢机制在SCD疼痛中的作用。在SCD疼痛研究中,应将内在脑连接性作为一种补充性和客观性的结果指标进行探索。
镰状细胞病患者中与高疼痛体验相关的连接模式改变表明中枢机制在镰状细胞疼痛中可能发挥作用。应探索静息态脑连接性研究作为调查SCD疼痛的有效方法。